Back
Piedmont Lithium Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
20
PLL
Piedmont Lithium
Last Price:
10.05
Seasonality Move:
-2.89%
Sell
44
RARE
Ultragenyx Pharmaceutical
Last Price:
41.40
Seasonality Move:
-0.9%
Sell
20
Piedmont Lithium (PLL)
is a Sell
Is Piedmont Lithium a Buy, Sell or Hold?
- The current Piedmont Lithium [PLL] share price is $9.91. The Score for PLL is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- PLL is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
44
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $40.50. The Score for RARE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PLL Stock Price Chart
What is Piedmont Lithium's stock price today?
-
The Piedmont Lithium share price today is $9.91
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLL is experiencing slight buying pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $40.50
The current trend is relatively stagnant and RARE is experiencing slight buying pressure.
PLL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.04 | Sell |
Relative Strength Index (14 RSI): | 32.12 | Sell |
Chaikin Money Flow: | 94532 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.44 - 14.06) | Sell |
Bollinger Bands (100): | (11.7 - 14.48) | Sell |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.6 | Sell |
Relative Strength Index (14 RSI): | 49.22 | Sell |
Chaikin Money Flow: | 494801 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.79 - 41.97) | Buy |
Bollinger Bands (100): | (40.81 - 48.79) | Sell |
PLL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.17 | Sell |
20-day SMA: | 11.58 | Sell |
50-day SMA: | 12.75 | Sell |
200-day SMA: | 21.18 | Sell |
8-day EMA: | 10.23 | Sell |
20-day EMA: | 11.35 | Sell |
50-day EMA: | 12.58 | Sell |
200-day EMA: | 21.97 | Sell |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.2 | Buy |
20-day SMA: | 40.42 | Buy |
50-day SMA: | 41.53 | Sell |
200-day SMA: | 42.45 | Sell |
8-day EMA: | 39.89 | Buy |
20-day EMA: | 40.39 | Buy |
50-day EMA: | 41.79 | Sell |
200-day EMA: | 43.35 | Sell |
Piedmont Lithium Earnings Growth & PLL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.50 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.52 per share, and an increase next year of $4.16 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.
Piedmont Lithium Technical Analysis
Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |